Literature DB >> 18518490

Role of secondary low-energy electrons in the concomitant chemoradiation therapy of cancer.

Yi Zheng1, Darel J Hunting, Patrick Ayotte, Léon Sanche.   

Abstract

Solid films of DNA with and without the chemotherapeutic agent cisplatin bonded to guanine were bombarded with electrons of 1, 10, 100, and 60,000 eV causing single and double strand breaks. In the presence of cisplatin this damage was increased by factors varying from 1.3 to 4.4 owing to an increase in bond dissociation triggered by the formation of transient anions. This mechanism may lie at the basis of the efficiency of concomitant cisplatin-radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18518490     DOI: 10.1103/PhysRevLett.100.198101

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  23 in total

1.  Measurements of G values for DNA damage induced by low-energy electrons.

Authors:  Elahe Alizadeh; Léon Sanche
Journal:  J Phys Chem B       Date:  2011-11-21       Impact factor: 2.991

2.  Damage to amino acid-nucleotide pairs induced by 1 eV electrons.

Authors:  Sylwia Ptasińska; Zejun Li; Nigel J Mason; Leon Sanche
Journal:  Phys Chem Chem Phys       Date:  2010-06-21       Impact factor: 3.676

3.  Low energy electron stimulated desorption from DNA films dosed with oxygen.

Authors:  Nasrin Mirsaleh-Kohan; Andrew D Bass; Pierre Cloutier; Sylvain Massey; Léon Sanche
Journal:  J Chem Phys       Date:  2012-06-21       Impact factor: 3.488

4.  DNA strand breaks and crosslinks induced by transient anions in the range 2-20 eV.

Authors:  Xinglan Luo; Yi Zheng; Léon Sanche
Journal:  J Chem Phys       Date:  2014-04-15       Impact factor: 3.488

5.  Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  J Neurooncol       Date:  2013-09-13       Impact factor: 4.130

6.  Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

7.  Hydrated electrons react with high specificity with cisplatin bound to single-stranded DNA.

Authors:  B Behmand; P Cloutier; S Girouard; J R Wagner; L Sanche; D J Hunting
Journal:  J Phys Chem B       Date:  2013-12-10       Impact factor: 2.991

8.  Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electrons.

Authors:  B Behmand; J R Wagner; L Sanche; D J Hunting
Journal:  J Phys Chem B       Date:  2014-04-29       Impact factor: 2.991

Review 9.  Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.

Authors:  Nathan B Roberts; Aniket S Wadajkar; Jeffrey A Winkles; Eduardo Davila; Anthony J Kim; Graeme F Woodworth
Journal:  Oncoimmunology       Date:  2016-08-19       Impact factor: 8.110

10.  New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.

Authors:  Yucel Altundal; Gizem Cifter; Alexandre Detappe; Erno Sajo; Panagiotis Tsiamas; Piotr Zygmanski; Ross Berbeco; Robert A Cormack; Mike Makrigiorgos; Wilfred Ngwa
Journal:  Phys Med       Date:  2014-12-06       Impact factor: 2.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.